The Impact of Substance Use on Adherence to Antiretroviral Therapy Among HIV-Infected Women in the United States
Research is scant regarding differential effects of specific types of recreational drugs use on antiretroviral therapy adherence among women, particularly to single-tablet regimens (STR). This is increasingly important in the context of marijuana legalization. We examined the effects of self-reporte...
Gespeichert in:
| Veröffentlicht in: | AIDS and behavior 2018-03, Vol.22 (3), p.896-908 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 908 |
|---|---|
| container_issue | 3 |
| container_start_page | 896 |
| container_title | AIDS and behavior |
| container_volume | 22 |
| creator | Zhang, Yuehan Wilson, Tracey E. Adedimeji, Adebola Merenstein, Daniel Milam, Joel Cohen, Jennifer Cohen, Mardge Golub, Elizabeth T. |
| description | Research is scant regarding differential effects of specific types of recreational drugs use on antiretroviral therapy adherence among women, particularly to single-tablet regimens (STR). This is increasingly important in the context of marijuana legalization. We examined the effects of self-reported substance use on suboptimal ( |
| doi_str_mv | 10.1007/s10461-017-1808-4 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5709246</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1904209025</sourcerecordid><originalsourceid>FETCH-LOGICAL-c470t-daff86ecf886a207579dc976d1347ab98a534b9edf6f613fdb92003a9c3eeaea3</originalsourceid><addsrcrecordid>eNp1kUtr3DAUhUVpaB7tD-imCLrpxs2VH5K1KQyhTQYCWSTTLoUsX804jCVXkgP595WZNH1AVhL3fvfoXB1C3jP4zADEeWRQc1YAEwVroS3qV-SENaIqqrKpX-c7SCgE480xOY3xHgAkF_INOS7bhkMt5QmZ7nZI1-OkTaLe0tu5i0k7g3QTkXpHV_0OAy6F5OnKpSFgCv5hCHpP82jQ0yNdjd5t6dX6e7F2Fk3Cnv7wIzo6OJqy_MYNS-026YTxLTmyeh_x3dN5Rjbfvt5dXBXXN5fri9V1YWoBqei1tS1HY9uW6xJEI2RvpOA9q2qhO9nqpqo7ib3llrPK9p0sASotTYWoUVdn5MtBd5q7EXuDLmXPagrDqMOj8npQ_3bcsFNb_6AaAbKseRb49CQQ_M8ZY1LjEA3u99qhn6NiEuoyf3DZZPTjf-i9n4PL66lsqi2lzIqZYgfKBB9jQPtshoFa8lSHPFXOUy15qmXmw99bPE_8DjAD5QGIueW2GP48_bLqL6OHrFs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2008299924</pqid></control><display><type>article</type><title>The Impact of Substance Use on Adherence to Antiretroviral Therapy Among HIV-Infected Women in the United States</title><source>MEDLINE</source><source>Sociological Abstracts</source><source>SpringerLink Journals - AutoHoldings</source><creator>Zhang, Yuehan ; Wilson, Tracey E. ; Adedimeji, Adebola ; Merenstein, Daniel ; Milam, Joel ; Cohen, Jennifer ; Cohen, Mardge ; Golub, Elizabeth T.</creator><creatorcontrib>Zhang, Yuehan ; Wilson, Tracey E. ; Adedimeji, Adebola ; Merenstein, Daniel ; Milam, Joel ; Cohen, Jennifer ; Cohen, Mardge ; Golub, Elizabeth T.</creatorcontrib><description>Research is scant regarding differential effects of specific types of recreational drugs use on antiretroviral therapy adherence among women, particularly to single-tablet regimens (STR). This is increasingly important in the context of marijuana legalization. We examined the effects of self-reported substance use on suboptimal (<95%) adherence in the Women’s Interagency HIV Study, 2003–2014. Among 1799 HIV-infected women, the most prevalent substance used was marijuana. In multivariable Poisson GEE regression, substance use overall was significantly associated with suboptimal adherence (adjusted prevalence ratio, aPR = 1.20, 95% CI 1.10–1.32), adjusting for STR use, socio-demographic, behavioral, and clinical factors. Among STR users, compared to no drug use, substance use overall remained detrimental to ART adherence (aPR = 1.61, 95% CI 1.24–2.09); specifically, both marijuana (aPR = 1.48, 95% CI: 1.11–1.97) and other drug use (aPR = 1.87, 95% CI 1.29–2.70) predicted suboptimal adherence. These findings highlight the need to intervene with drug-using women taking antiretroviral therapy to maintain effective adherence.</description><identifier>ISSN: 1090-7165</identifier><identifier>ISSN: 1573-3254</identifier><identifier>EISSN: 1573-3254</identifier><identifier>DOI: 10.1007/s10461-017-1808-4</identifier><identifier>PMID: 28560499</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Acquired immune deficiency syndrome ; Adhesion ; Adult ; AIDS ; Antiretroviral agents ; Antiretroviral drugs ; Antiretroviral therapy ; Antiretroviral Therapy, Highly Active ; Cannabis ; Decriminalization ; Demographics ; Drug abuse ; Drug legalization ; Drug policy ; Drug therapy ; Drug use ; Female ; Health Psychology ; HIV ; HIV Infections - drug therapy ; HIV Infections - psychology ; Human immunodeficiency virus ; Humans ; Illicit Drugs ; Infectious Diseases ; Marijuana ; Marijuana Smoking - epidemiology ; Marijuana Smoking - psychology ; Marijuana Smoking - trends ; Medication Adherence - psychology ; Medication Adherence - statistics & numerical data ; Medicine ; Medicine & Public Health ; Middle Aged ; Original Paper ; Prescription drugs ; Prevalence ; Public Health ; Recreational use ; Sociodemographics ; Substance abuse ; Substance use ; Substance-Related Disorders - complications ; Tablets ; Therapy ; United States - epidemiology ; Women ; Womens health</subject><ispartof>AIDS and behavior, 2018-03, Vol.22 (3), p.896-908</ispartof><rights>Springer Science+Business Media New York 2017</rights><rights>AIDS and Behavior is a copyright of Springer, (2017). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c470t-daff86ecf886a207579dc976d1347ab98a534b9edf6f613fdb92003a9c3eeaea3</citedby><cites>FETCH-LOGICAL-c470t-daff86ecf886a207579dc976d1347ab98a534b9edf6f613fdb92003a9c3eeaea3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10461-017-1808-4$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10461-017-1808-4$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,780,784,885,27344,27924,27925,33774,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28560499$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhang, Yuehan</creatorcontrib><creatorcontrib>Wilson, Tracey E.</creatorcontrib><creatorcontrib>Adedimeji, Adebola</creatorcontrib><creatorcontrib>Merenstein, Daniel</creatorcontrib><creatorcontrib>Milam, Joel</creatorcontrib><creatorcontrib>Cohen, Jennifer</creatorcontrib><creatorcontrib>Cohen, Mardge</creatorcontrib><creatorcontrib>Golub, Elizabeth T.</creatorcontrib><title>The Impact of Substance Use on Adherence to Antiretroviral Therapy Among HIV-Infected Women in the United States</title><title>AIDS and behavior</title><addtitle>AIDS Behav</addtitle><addtitle>AIDS Behav</addtitle><description>Research is scant regarding differential effects of specific types of recreational drugs use on antiretroviral therapy adherence among women, particularly to single-tablet regimens (STR). This is increasingly important in the context of marijuana legalization. We examined the effects of self-reported substance use on suboptimal (<95%) adherence in the Women’s Interagency HIV Study, 2003–2014. Among 1799 HIV-infected women, the most prevalent substance used was marijuana. In multivariable Poisson GEE regression, substance use overall was significantly associated with suboptimal adherence (adjusted prevalence ratio, aPR = 1.20, 95% CI 1.10–1.32), adjusting for STR use, socio-demographic, behavioral, and clinical factors. Among STR users, compared to no drug use, substance use overall remained detrimental to ART adherence (aPR = 1.61, 95% CI 1.24–2.09); specifically, both marijuana (aPR = 1.48, 95% CI: 1.11–1.97) and other drug use (aPR = 1.87, 95% CI 1.29–2.70) predicted suboptimal adherence. These findings highlight the need to intervene with drug-using women taking antiretroviral therapy to maintain effective adherence.</description><subject>Acquired immune deficiency syndrome</subject><subject>Adhesion</subject><subject>Adult</subject><subject>AIDS</subject><subject>Antiretroviral agents</subject><subject>Antiretroviral drugs</subject><subject>Antiretroviral therapy</subject><subject>Antiretroviral Therapy, Highly Active</subject><subject>Cannabis</subject><subject>Decriminalization</subject><subject>Demographics</subject><subject>Drug abuse</subject><subject>Drug legalization</subject><subject>Drug policy</subject><subject>Drug therapy</subject><subject>Drug use</subject><subject>Female</subject><subject>Health Psychology</subject><subject>HIV</subject><subject>HIV Infections - drug therapy</subject><subject>HIV Infections - psychology</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Illicit Drugs</subject><subject>Infectious Diseases</subject><subject>Marijuana</subject><subject>Marijuana Smoking - epidemiology</subject><subject>Marijuana Smoking - psychology</subject><subject>Marijuana Smoking - trends</subject><subject>Medication Adherence - psychology</subject><subject>Medication Adherence - statistics & numerical data</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Original Paper</subject><subject>Prescription drugs</subject><subject>Prevalence</subject><subject>Public Health</subject><subject>Recreational use</subject><subject>Sociodemographics</subject><subject>Substance abuse</subject><subject>Substance use</subject><subject>Substance-Related Disorders - complications</subject><subject>Tablets</subject><subject>Therapy</subject><subject>United States - epidemiology</subject><subject>Women</subject><subject>Womens health</subject><issn>1090-7165</issn><issn>1573-3254</issn><issn>1573-3254</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>BHHNA</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp1kUtr3DAUhUVpaB7tD-imCLrpxs2VH5K1KQyhTQYCWSTTLoUsX804jCVXkgP595WZNH1AVhL3fvfoXB1C3jP4zADEeWRQc1YAEwVroS3qV-SENaIqqrKpX-c7SCgE480xOY3xHgAkF_INOS7bhkMt5QmZ7nZI1-OkTaLe0tu5i0k7g3QTkXpHV_0OAy6F5OnKpSFgCv5hCHpP82jQ0yNdjd5t6dX6e7F2Fk3Cnv7wIzo6OJqy_MYNS-026YTxLTmyeh_x3dN5Rjbfvt5dXBXXN5fri9V1YWoBqei1tS1HY9uW6xJEI2RvpOA9q2qhO9nqpqo7ib3llrPK9p0sASotTYWoUVdn5MtBd5q7EXuDLmXPagrDqMOj8npQ_3bcsFNb_6AaAbKseRb49CQQ_M8ZY1LjEA3u99qhn6NiEuoyf3DZZPTjf-i9n4PL66lsqi2lzIqZYgfKBB9jQPtshoFa8lSHPFXOUy15qmXmw99bPE_8DjAD5QGIueW2GP48_bLqL6OHrFs</recordid><startdate>20180301</startdate><enddate>20180301</enddate><creator>Zhang, Yuehan</creator><creator>Wilson, Tracey E.</creator><creator>Adedimeji, Adebola</creator><creator>Merenstein, Daniel</creator><creator>Milam, Joel</creator><creator>Cohen, Jennifer</creator><creator>Cohen, Mardge</creator><creator>Golub, Elizabeth T.</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7RV</scope><scope>7T2</scope><scope>7U3</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AM</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BGRYB</scope><scope>BHHNA</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HEHIP</scope><scope>K7.</scope><scope>K9.</scope><scope>KB0</scope><scope>M0O</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2S</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20180301</creationdate><title>The Impact of Substance Use on Adherence to Antiretroviral Therapy Among HIV-Infected Women in the United States</title><author>Zhang, Yuehan ; Wilson, Tracey E. ; Adedimeji, Adebola ; Merenstein, Daniel ; Milam, Joel ; Cohen, Jennifer ; Cohen, Mardge ; Golub, Elizabeth T.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c470t-daff86ecf886a207579dc976d1347ab98a534b9edf6f613fdb92003a9c3eeaea3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Acquired immune deficiency syndrome</topic><topic>Adhesion</topic><topic>Adult</topic><topic>AIDS</topic><topic>Antiretroviral agents</topic><topic>Antiretroviral drugs</topic><topic>Antiretroviral therapy</topic><topic>Antiretroviral Therapy, Highly Active</topic><topic>Cannabis</topic><topic>Decriminalization</topic><topic>Demographics</topic><topic>Drug abuse</topic><topic>Drug legalization</topic><topic>Drug policy</topic><topic>Drug therapy</topic><topic>Drug use</topic><topic>Female</topic><topic>Health Psychology</topic><topic>HIV</topic><topic>HIV Infections - drug therapy</topic><topic>HIV Infections - psychology</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Illicit Drugs</topic><topic>Infectious Diseases</topic><topic>Marijuana</topic><topic>Marijuana Smoking - epidemiology</topic><topic>Marijuana Smoking - psychology</topic><topic>Marijuana Smoking - trends</topic><topic>Medication Adherence - psychology</topic><topic>Medication Adherence - statistics & numerical data</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Original Paper</topic><topic>Prescription drugs</topic><topic>Prevalence</topic><topic>Public Health</topic><topic>Recreational use</topic><topic>Sociodemographics</topic><topic>Substance abuse</topic><topic>Substance use</topic><topic>Substance-Related Disorders - complications</topic><topic>Tablets</topic><topic>Therapy</topic><topic>United States - epidemiology</topic><topic>Women</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhang, Yuehan</creatorcontrib><creatorcontrib>Wilson, Tracey E.</creatorcontrib><creatorcontrib>Adedimeji, Adebola</creatorcontrib><creatorcontrib>Merenstein, Daniel</creatorcontrib><creatorcontrib>Milam, Joel</creatorcontrib><creatorcontrib>Cohen, Jennifer</creatorcontrib><creatorcontrib>Cohen, Mardge</creatorcontrib><creatorcontrib>Golub, Elizabeth T.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Social Services Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Criminal Justice Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Social Science Premium Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Criminology Collection</collection><collection>Sociological Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Sociology Collection</collection><collection>ProQuest Criminal Justice (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Criminal Justice Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Sociology Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>AIDS and behavior</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhang, Yuehan</au><au>Wilson, Tracey E.</au><au>Adedimeji, Adebola</au><au>Merenstein, Daniel</au><au>Milam, Joel</au><au>Cohen, Jennifer</au><au>Cohen, Mardge</au><au>Golub, Elizabeth T.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Impact of Substance Use on Adherence to Antiretroviral Therapy Among HIV-Infected Women in the United States</atitle><jtitle>AIDS and behavior</jtitle><stitle>AIDS Behav</stitle><addtitle>AIDS Behav</addtitle><date>2018-03-01</date><risdate>2018</risdate><volume>22</volume><issue>3</issue><spage>896</spage><epage>908</epage><pages>896-908</pages><issn>1090-7165</issn><issn>1573-3254</issn><eissn>1573-3254</eissn><abstract>Research is scant regarding differential effects of specific types of recreational drugs use on antiretroviral therapy adherence among women, particularly to single-tablet regimens (STR). This is increasingly important in the context of marijuana legalization. We examined the effects of self-reported substance use on suboptimal (<95%) adherence in the Women’s Interagency HIV Study, 2003–2014. Among 1799 HIV-infected women, the most prevalent substance used was marijuana. In multivariable Poisson GEE regression, substance use overall was significantly associated with suboptimal adherence (adjusted prevalence ratio, aPR = 1.20, 95% CI 1.10–1.32), adjusting for STR use, socio-demographic, behavioral, and clinical factors. Among STR users, compared to no drug use, substance use overall remained detrimental to ART adherence (aPR = 1.61, 95% CI 1.24–2.09); specifically, both marijuana (aPR = 1.48, 95% CI: 1.11–1.97) and other drug use (aPR = 1.87, 95% CI 1.29–2.70) predicted suboptimal adherence. These findings highlight the need to intervene with drug-using women taking antiretroviral therapy to maintain effective adherence.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>28560499</pmid><doi>10.1007/s10461-017-1808-4</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1090-7165 |
| ispartof | AIDS and behavior, 2018-03, Vol.22 (3), p.896-908 |
| issn | 1090-7165 1573-3254 1573-3254 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5709246 |
| source | MEDLINE; Sociological Abstracts; SpringerLink Journals - AutoHoldings |
| subjects | Acquired immune deficiency syndrome Adhesion Adult AIDS Antiretroviral agents Antiretroviral drugs Antiretroviral therapy Antiretroviral Therapy, Highly Active Cannabis Decriminalization Demographics Drug abuse Drug legalization Drug policy Drug therapy Drug use Female Health Psychology HIV HIV Infections - drug therapy HIV Infections - psychology Human immunodeficiency virus Humans Illicit Drugs Infectious Diseases Marijuana Marijuana Smoking - epidemiology Marijuana Smoking - psychology Marijuana Smoking - trends Medication Adherence - psychology Medication Adherence - statistics & numerical data Medicine Medicine & Public Health Middle Aged Original Paper Prescription drugs Prevalence Public Health Recreational use Sociodemographics Substance abuse Substance use Substance-Related Disorders - complications Tablets Therapy United States - epidemiology Women Womens health |
| title | The Impact of Substance Use on Adherence to Antiretroviral Therapy Among HIV-Infected Women in the United States |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T16%3A17%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Impact%20of%20Substance%20Use%20on%20Adherence%20to%20Antiretroviral%20Therapy%20Among%20HIV-Infected%20Women%20in%20the%20United%20States&rft.jtitle=AIDS%20and%20behavior&rft.au=Zhang,%20Yuehan&rft.date=2018-03-01&rft.volume=22&rft.issue=3&rft.spage=896&rft.epage=908&rft.pages=896-908&rft.issn=1090-7165&rft.eissn=1573-3254&rft_id=info:doi/10.1007/s10461-017-1808-4&rft_dat=%3Cproquest_pubme%3E1904209025%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2008299924&rft_id=info:pmid/28560499&rfr_iscdi=true |